MCM
PFE icon

Maple Capital Management’s Pfizer PFE Stock Holding History

Maple Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$204K Sell
7,257
-1,290
-15% -$34.3K 0.01% 114
2025
Q4 		$213K Sell
8,547
-2,936
-26% -$74K 0.01% 113
2025
Q3 		$293K Sell
11,483
-1,976
-15% -$48.8K 0.02% 96
2025
Q2 		$326K Sell
13,459
-1,410
-9% -$32.9K 0.02% 92
2025
Q1 		$377K Sell
14,869
-2,650
-15% -$69.3K 0.03% 88
2024
Q4 		$465K Sell
17,519
-1,861
-10% -$50.5K 0.03% 80
2024
Q3 		$561K Sell
19,380
-572
-3% -$16.7K 0.04% 71
2024
Q2 		$558K Sell
19,952
-1,991
-9% -$54.8K 0.05% 72
2024
Q1 		$609K Sell
21,943
-2,289
-9% -$63.5K 0.06% 61
2023
Q4 		$698K Sell
24,232
-3,420
-12% -$103K 0.07% 58
2023
Q3 		$917K Buy
27,652
+486
+2% +$17.2K 0.1% 51
2023
Q2 		$996K Buy
27,166
+1,813
+7% +$70.6K 0.11% 49
2023
Q1 		$1.03M Buy
25,353
+332
+1% +$14.3K 0.13% 46
2022
Q4 		$1.28M Buy
25,021
+772
+3% +$37K 0.17% 45
2022
Q3 		$1.19M Buy
24,249
+813
+3% +$39.5K 0.15% 47
2022
Q2 		$1.23M Sell
23,436
-3
-0% -$153 0.16% 48
2022
Q1 		$1.21M Buy
23,439
+546
+2% +$28.3K 0.14% 50
2021
Q4 		$1.35M Buy
22,893
+583
+3% +$28.9K 0.15% 47
2021
Q3 		$960K Sell
22,310
-147
-0.7% -$6.51K 0.12% 52
2021
Q2 		$1.09M Buy
22,457
+2,139
+11% +$83.2K 0.13% 52
2021
Q1 		$736K Buy
20,318
+1,208
+6% +$42.9K 0.11% 57
2020
Q4 		$703K Sell
19,110
-1,216
-6% -$44.6K 0.11% 63
2020
Q3 		$745K Sell
20,326
-370
-2% -$13K 0.12% 61
2020
Q2 		$642K Sell
20,696
-9,361
-31% -$318K 0.13% 64
2020
Q1 		$931K Sell
30,057
-1,455
-5% -$49.6K 0.23% 49
2019
Q4 		$1.17M Sell
31,512
-3,505
-10% -$125K 0.23% 55
2019
Q3 		$1.19M Sell
35,017
-2,629
-7% -$95.6K 0.26% 52
2019
Q2 		$1.55M Buy
37,646
+7,893
+27% +$313K 0.35% 44
2019
Q1 		$1.2M Sell
29,753
-5,847
-16% -$234K 0.28% 51
2018
Q4 		$1.47M Sell
35,600
-157
-0.4% -$6.52K 0.38% 48
2018
Q3 		$1.5M Sell
35,757
-4,156
-10% -$160K 0.34% 46
2018
Q2 		$1.37M Sell
39,913
-1,765
-4% -$60.3K 0.34% 49
2018
Q1 		$1.4M Sell
41,678
-936
-2% -$32.2K 0.35% 54
2017
Q4 		$1.46M Sell
42,614
-697
-2% -$23.8K 0.38% 52
2017
Q3 		$1.47M Sell
43,311
-2,673
-6% -$85.9K 0.39% 50
2017
Q2 		$1.47M Sell
45,984
-1,194
-3% -$37.7K 0.42% 49
2017
Q1 		$1.53M Sell
47,178
-4,672
-9% -$147K 0.45% 51
2016
Q4 		$1.6M Buy
51,850
+436
+0.8% +$13.3K 0.5% 49
2016
Q3 		$1.65M Buy
51,414
+2,872
+6% +$96K 0.54% 48
2016
Q2 		$1.62M Sell
48,542
-39
-0.1% -$1.25K 0.59% 46
2016
Q1 		$1.37M Buy
48,581
+580
+1% +$16.6K 0.5% 48
2015
Q4 		$1.47M Buy
48,001
+818
+2% +$25.7K 0.52% 50
2015
Q3 		$1.41M Buy
47,183
+2,740
+6% +$87.9K 0.52% 52
2015
Q2 		$1.41M Buy
44,443
+4,005
+10% +$131K 0.48% 54
2015
Q1 		$1.33M Buy
40,438
+791
+2% +$25.1K 0.46% 55
2014
Q4 		$1.17M Buy
39,647
+1,555
+4% +$44.6K 0.42% 57
2014
Q3 		$1.07M Buy
38,092
+870
+2% +$24.4K 0.41% 59
2014
Q2 		$1.05M Buy
37,222
+11,436
+44% +$326K 0.38% 63
2014
Q1 		$786K Buy
25,786
+948
+4% +$28.3K 0.3% 71
2013
Q4 		$722K Buy
24,838
+3,902
+19% +$114K 0.29% 67
2013
Q3 		$571K Buy
20,936
+475
+2% +$12.9K 0.25% 74
2013
Q2 		$544K Buy
+20,461
New +$565K 0.24% 75

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Maple Capital Management's PFE Position: Q1 2026 in Review

Maple Capital Management reduced its Pfizer (PFE) stake by 15% in Q1 2026, selling an estimated $34.3K and leaving 7,257 shares worth $204K. The position accounts for 0.01% of the portfolio, ranked #114.

Maple Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.65M in Q3 2016. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Maple Capital Management held 7,257 shares of Pfizer worth $204K as of Q1 2026.
  • Maple Capital Management sold 1,290 Pfizer shares in Q1 2026, an estimated $34.3K.
  • Pfizer made up 0.01% of Maple Capital Management's portfolio in Q1 2026, its #114 holding.
  • Maple Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Maple Capital Management's Pfizer position peaked at $1.65M in Q3 2016.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Maple Capital Management's 13F filing for Q1 2026, filed 8 May 2026.